Trials / Unknown
UnknownNCT06193538
The Safety and Effectiveness of NV-A01 in Glioma Patients
Clinical Study on the Safety and Effectiveness of NV-A01 in the Treatment of Advanced Glioma Patients
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- First Affiliated Hospital of Wannan Medical College · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to learn about the safety and effectiveness of NV-A01 in the treatment of advanced glioma patients. The main questions it aims to answer are: 1. The safety of NV-A01 in the treatment of advanced glioblastoma patients. 2. The effectiveness of NV-A01 in treating patients with advanced glioblastoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Recombinant NV-A01 adenovirus injection | Patients with advanced glioblastoma were intratumoral injected with NV-A01. Or the NV-A01 was injected after tumor resection. |
Timeline
- Start date
- 2023-09-14
- Primary completion
- 2024-12-01
- Completion
- 2025-07-01
- First posted
- 2024-01-05
- Last updated
- 2024-01-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06193538. Inclusion in this directory is not an endorsement.